Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Tenax Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- 0 vs. Q1 2022
- Shares held
- 6.93M
- −1.15M (−14.3%) vs. Q1 2022
- Total value
- $2.08M
- −$4.46M (−68.2%) vs. Q1 2022
- New holders
- 5
- 2 more added
- Sold out
- 5
- 3 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Banque Cantonale Vaudoise | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 100 | $0 | 0.00% | +8+8.7% | Added |
| Umb Bank N A | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Skandinaviska Enskilda Banken AB (publ) | 140 | $0 | 0.00% | 00.0% | Unchanged |
| Hudock, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 1 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 24 | $0 | 0.00% | 00.0% | Unchanged |
| Horan Securities, Inc. | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Laurel Wealth Planning LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Credit Suisse AG | 100 | $0 | 0.00% | +100 | New |
| Tower Research Capital LLC (TRC) | 9,628 | $3.00K | 0.00% | +4,806+99.7% | Added |
| Millennium Management LLC | 10,784 | $3.00K | 0.00% | +10,784 | New |
| Citigroup Inc | 13,500 | $4.00K | 0.00% | +13,500 | New |
| Two Sigma Securities, LLC | 18,980 | $6.00K | 0.00% | +18,980 | New |
| Northern Trust Corp | 34,671 | $10.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 51,212 | $15.0K | 0.00% | 00.0% | Unchanged |
| Financial Advisory Service, Inc. | 58,326 | $17.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 66,232 | $20.0K | 0.00% | −1,200−1.8% | Reduced |
| Citadel Advisors LLC | 72,900 | $22.0K | 0.00% | +72,900 | New |
| State Street Corp | 138,407 | $42.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 200,000 | $60.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 358,978 | $108.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 479,065 | $144.0K | 0.00% | −31,653−6.2% | Reduced |
| Armistice Capital, LLC | 1,597,049 | $479.0K | 0.01% | −422,946−20.9% | Reduced |
| Gofen & Glossberg LLC | 3,819,170 | $1.15M | 0.03% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −735,097−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −71,808−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,658−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −2−100.0% | Sold out |